Clinical role of the renal transplant biopsy
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Percutaneous needle core biopsy is the definitive procedure by which essential diagnostic and prognostic information on acute and chronic renal allograft dysfunction is obtained. The diagnostic value of the information so obtained has endured for over three decades and has proven crucially important in shaping strategies for therapeutic intervention. This Review provides a broad outline of the utility of performing kidney graft biopsies after transplantation, highlighting the relevance of biopsy findings in the immediate and early post-transplant period (from days to weeks after implantation), the first post-transplant year, and the late period (beyond the first year). We focus on how biopsy findings change over time, and the wide variety of pathological features that characterize the major clinical diagnoses facing the clinician. This article also includes a discussion of acute cellular and humoral rejection, the toxic effects of calcineurin inhibitors, and the widely varying etiologies and characteristics of chronic lesions. Emerging technologies based on gene expression analyses and proteomics, the in situ detection of functionally relevant molecules, and new bioinformatic approaches that hold the promise of improving diagnostic precision and developing new, refined molecular pathways for therapeutic intervention are also presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
Beck, L. H., Bonegio, R. G. B., Lambeau, G., Beck, D. M., Powell, D. W., Cummins, T. D., Klein, J. B., & Salant, D. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810457 · Cited by 2,347
THE CLINICAL USEFULNESS OF THE RENAL ALLOGRAFT BIOPSY IN THE CYCLOSPORINE ERA: A Prospective Study1
Pascual, M., Vallhonrat, H., Cosimi, A. B., Tolkoff-Rubin, N., Colvin, R. B., Delmonico, F. L., Ko, D. S. C., Schoenfeld, D. A., & Williams, W. W. (1999) · Transplantation · doi:10.1097/00007890-199903150-00016 · Cited by 58
Self-citation
Cited by
Urinary-cell mRNA Profile and Acute Cellular Rejection in Kidney Allografts
Suthanthiran, M., Schwartz, J. E., Ding, R., Abecassis, M., Dadhania, D., Samstein, B., Knechtle, S. J., Friedewald, J., Becker, Y. T., Sharma, V. K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215555 · Cited by 363
Valenzuela, N. M., & Reed, E. F. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90597 · Cited by 215
“For example, transplant glomerulopathy is a feature of chronic AMR in renal allografts, with duplication of the basement membrane in the glomerulus and peritubular capillaries (173).”
Background
Metadata
- Authors
- Williams, W. W., Taheri, D., Tolkoff-Rubin, N., & Colvin, R. B.
- Venue
- Nature Reviews Nephrology
- Published
- 2012-01-10
- Volume
- 8
- Issue
- 2
- Pages
- 110-121
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W1988888376
- Cited by
- 159
- References
- 2
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.